Companion Animal Ear Infection Treatment Market to Grow with a CAGR of 6.84% through 2028
Growing
importance of pet health and the increasing awareness among pet owners is
expected to drive the Global Companion Animal Ear Infection Treatment Market growth
in the forecast period, 2024-2028.
According to
TechSci Research report, “Companion Animal Ear Infection Treatment Market – Global
Industry Size, Share, Trends, Competition Forecast & Opportunities,
2028”, the Global Companion Animal Ear Infection Treatment Market stood at
USD 563.10 million in 2022 and is anticipated to grow with a CAGR of 6.84% in
the forecast period, 2024-2028. This can be attributed to awareness and education.
Growing awareness among pet owners about the importance of early diagnosis and
treatment of ear infections has been instrumental in market growth. Pet owners
are increasingly educated about the signs and symptoms of ear infections,
encouraging them to seek professional veterinary care when needed. This
increased awareness has also led to more proactive pet healthcare practices,
which often include routine ear examinations.
Furthermore,
given growing concerns about antibiotic resistance, antibiotic stewardship is
becoming a critical trend. Veterinarians are increasingly cautious about
antibiotic use, reserving them for cases where they are truly necessary. This
trend aligns with broader efforts to promote responsible antibiotic use in
veterinary medicine.
The market is
experiencing growth driven by several factors, including the increasing
incidence of Otitis Externa (OE) in pets and the growing population of companion
animals. OE, characterized by ear inflammation or infection, is a significant
contributor to market expansion, primarily due to its high occurrence in dogs
and cats. The chronic and recurring nature of this condition necessitates
veterinary intervention, further propelling market growth. Additionally, pet
owners are increasingly prioritizing their pets' well-being and are willing to
invest in their healthcare. Dechra Pharmaceuticals reports that currently,
otitis is diagnosed in 2% of feline consultations and 5% of canine
consultations. Furthermore, Merck & Co., Inc. indicates that otitis is the
most frequently diagnosed disease by veterinarians in puppies, with specific
breeds like Cocker Spaniels and German Shepherds being particularly susceptible,
as noted by the American College of Veterinary Surgeons (ACVS).
The growth in
the pet population and advancements in technology are driving the demand for
veterinary healthcare services and increasing overall spending on pets.
Heightened awareness of the importance of maintaining pets' health is leading
to a greater emphasis on preventive care and timely treatment of ear
infections. In 2022, 44.5% of U.S. households owned dogs, and 29.0% owned cats,
highlighting the expanding awareness and commitment to pet well-being, which
contribute to market growth.
In June 2021,
Covetrus, a provider of animal health technology and services, entered into an
agreement to acquire VCP, a company specializing in wellness plan management
solutions. VCP's technology platform is expected to empower Covetrus by
offering veterinarians new avenues to strengthen their relationships with
clients and deliver positive healthcare outcomes.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "CompanionAnimal Ear Infection Treatment Market.”
The Global Companion
Animal Ear Infection Treatment Market is segmented into product, disease type,
mode of administration, animal type, regional distribution, and company.
Based on its animal
type, the dog category claimed the largest share of revenue in 2022. Ear
infections in dogs rank as the second most common medical issue prompting
veterinary visits, as revealed by a 2020 Nationwide study. Furthermore, the
growing ownership of dogs, both in developed and developing nations, is a
significant factor contributing to the expansion of this category. According to
data from the American Pet Products Association (APPA), in the United States
alone, 66% of households (equivalent to 86.9 million homes) have pets.
Conversely, the
cat category is anticipated to exhibit the most rapid CAGR during the forecast
period. This growth is propelled by heightened concerns regarding the health
and hygiene of cats. The younger population, particularly millennials, are
increasingly conscientious when it comes to the well-being of their pet cats.
Treating ear infections in cats often involves a combination of cold laser
therapy and medications to alleviate pain and reduce inflammation. Additionally,
topical anti-parasitic medications are commonly employed for the treatment of
ear mites in cats.
Based on disease
type, the otitis externa (OE) category commanded the largest share of revenue
in 2022. Due to the unique quadruped ear canal structure in pets, infections
are not always immediately noticeable, potentially leading to worsening
conditions if left untreated. Symptoms include skin swelling, itching, redness,
head shaking, increased discharge, and scaly skin. Allergies have been
identified as the primary cause of OE in most studies. Moreover, the American
Veterinary Medical Association (AVMA) reports that up to 16.5% of dogs
experience OE and related complications at least once during their lifetime,
which can progress into more severe ear infections. The development of new
medications for treating OE has contributed to market growth. For instance, in
October 2022, MSD Animal Health announced the approval of MOMETAMAX ULTRA by
the Committee for Veterinary Medicinal Products (CVMP), a single-dose topical
medicine for curing OE in dogs.
On the other
hand, the otitis media segment is expected to exhibit the fastest CAGR during
the forecast period. Otitis media primarily affects the middle part of the ear
canal and typically occurs as a secondary development in about 50% of chronic
OE cases. The most common bacteria responsible for otitis media is
Staphylococcus spp., with other bacteria including Pseudomonas, Proteus,
Enterococcus, Streptococcus, and Corynebacterium. Although rare in horses, when
infected, otitis media can potentially become a dangerous condition or evolve
into a chronic state if left untreated. According to information from Merck
& Co., Inc., severe inner or middle ear infections in horses may lead to
bony overgrowth and tympanohyoid joint fracture. This fracture has the
potential to extend into the skull, potentially resulting in infection or fatal
bleeding within the skull.
Major companies
operating in Global Companion Animal Ear Infection Treatment Market are:
- Zoetis Inc.
- Elanco LLC
- Dechra Pharmaceuticals PLC
- Merck & Co
- Vetoquinol SA
- Penn Veterinary Supply Inc
- Virbac SA
- Vedco Inc
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“As the bond
between pet owners and their furry companions deepens, the demand for advanced
and tailored ear infection treatments will continue to grow. The upcoming
trends not only reflect the industry's commitment to improving pet health but
also underscore its adaptability and responsiveness to the evolving needs of
pets and their owners. The future of the companion animal ear infection
treatment market is bright, with innovation and compassion driving its progress,”
said Mr. Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Companion Animal Ear Infection Treatment Market By Product
(Anti-bacterial, Anti-fungal, Corticosteroids, Others), By Disease Type (Otitis
Externa, Otitis Media, Otitis Interna), By Mode of Administration (Topical,
Oral, Otic), By Animal Type (Dogs, Cats, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”,
has evaluated the future growth potential of Global Companion Animal Ear
Infection Treatment Market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Companion
Animal Ear Infection Treatment Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com